Table 1 Demographic and clinical characteristics of participants

Age

39.9

37.2

1.522^a

0.1311

Weight (kg)

67.2

69.6

1.347^a

0.1811

Height (cm)

169.8

171.4

2.021^a

0.046

BMI

23.3

23.7

0.7063^a

0.4817

BMI classification [n (% BMI < 18.5)]

4 (8)

0 (0)

4.167^b

0.0412

BMI classification [n (% 18.5 ≤ BMI < 24)]

27 (54)

27 (54)

0^b

1

BMI classification [n (% 24 ≤ BMI < 28)]

15 (30)

23 (46)

2.716^b

0.0993

BMI classification [n (% 28 ≤ BMI)]

4 (8)

0 (0)

4.167^b

0.0412

Hepatitis B [n (%)]

1 (2)

0 (0)

1.010^b

0.3149

Antibiotic use [n (% in past 3 months)]

0

0

-

-

Antipsychotic use

0

0

-

-

Risperidone [n (%)]

14 (28)

0 (0)

16.28^b

5.00E-05

Clozapine [n (%)]

10 (20)

0 (0)

11.11^b

8.60E-04

Olanzapine [n (%)]

20 (40)

0 (0)

25.00^b

0

Quetiapine [n (%)]

12 (24)

0 (0)

13.64^b

2.20E-04

Sulpiride [n (%)]

1 (2)

0 (0)

1.010^b

0.3149

Aripiprazole [n (%)]

3 (6)

0 (0)

3.093^b

0.0786

Perphenazine tablets [n (%)]

1 (2)

0 (0)

1.010^b

0.3149